Surveillance, diagnosis and management of Clostridium difficile infection in Ireland: national clinical guideline No. 3: summary

dc.contributor.author	National Clinical Effectiveness Committee (NCEC)
dc.date.accessioned	2014-07-29T09:41:57Z
dc.date.available	2014-07-29T09:41:57Z
dc.date.issued	2014-06-12
dc.identifier.citation	National Clinical Effectiveness Council. Surveillance, diagnosis and management of Clostridium difficile infection in Ireland: national clinical guideline No. 3: summary. Dublin: HSE; 2014	en_GB
dc.identifier.uri	http://hdl.handle.net/10147/323892
dc.description	Clostridium difficile is the leading cause of infectious nosocomial diarrhoea in the industrialised world.	en_GB
dc.language.iso	en	en
dc.publisher	Department of Health, Health Service Executive	en_GB
dc.relation.url	http://www.hpsc.ie/A-Z/Gastroenteric/Clostridiumdifficile/Guidelines/File,13951,en.pdf	en_GB
dc.subject	INFECTION CONTROL	en_GB
dc.subject	COMMUNICABLE DISEASE	en_GB
dc.subject.other	CLOSTRIDIUM DIFFICILE	en_GB
dc.subject.other	DIARRHOEA	en_GB
dc.title	Surveillance, diagnosis and management of Clostridium difficile infection in Ireland: national clinical guideline No. 3: summary	en_GB
dc.type	Guideline	en
dc.contributor.department	CDI Clinical Guidelines Development Group	en_GB
refterms.dateFOA	2018-08-24T13:34:00Z

Name:

National Clinical Guideline No ...

Size:

785.0Kb

Format:

PDF

Description:

Clinical guideline summary